PRIVATE EQUITY INVESTMENTS IN INDIA’S HEALTHCARE SECTOR: REGULATORY CONSTRAINTS AND INVESTMENT STRUCTURING

AUTHOR – B J LAKSHMI, STUDENT AT SCHOOL OF LAW, CHRIST (DEEMED TO BE UNIVERSITY)

BEST CITATION – B J LAKSHMI, PRIVATE EQUITY INVESTMENTS IN INDIA’S HEALTHCARE SECTOR: REGULATORY CONSTRAINTS AND INVESTMENT STRUCTURING, INDIAN JOURNAL OF LEGAL REVIEW (IJLR), 6 (3) OF 2026, PG. 246-259, APIS – 3920 – 0001 & ISSN – 2583-2344.

Abstract

Over the last decade, India has become one of the most important targets of the private equity (PE) investment in the healthcare sector. The fast rise in the need of healthcare, the increase in the level of income, and the lack of infrastructure in the field of social healthcare have stimulated significant institutional capital flows towards the hospital chains, diagnostics chains, and healthcare services platforms. Although, the role of a private equity investment in the development of healthcare infrastructure and operational efficiency is significant, the sphere of investments is regulated by complex corporate regulations including corporate law, foreign investment regulations, and professional medical regulations. This paper investigates regulatory limitations and the system of structuring the investments that are linked with the involvement of the private equity in the healthcare industry in India.

The first part of the study is to analyze the legal frameworks that govern the healthcare investment and the chosen legal frameworks are corporate governance of the Companies Act, 2013, foreign investment regulation of the Foreign Exchange Management Act, 1999 and the Consolidated Foreign Direct Investment Policy of the Department of Promotion of Industry and Internal Trade, and professional regulation of the National Medical Commission Act, 2019. The paper also reveals major issues in structuring an investment such as the decoupling of ownership of the economy versus the clinical authority, the asset light hospital model, and the concept of a consolidating strategy in the diagnostic networks. The paper uses case studies of key healthcare investments to demonstrate how the investors of the private equity can design transactions in order to overcome regulatory limitations and contribute to the development of the sector.

Lastly, the paper makes a comparative study with the United States and suggests the regulatory reforms that can enhance the governance protections and regulatory clarity in the healthcare investment structures. The article posits that a middle ground in regulatory policies is required to promote the involvement of the private capital and protect the autonomy of the medical patients and the welfare of Indian healthcare system in the new ecosystem.